Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 18/20 | 0.53 |
| ▸ | CA1 | P00915 | 17/20 | 0.53 |
| ▸ | CA4 | P22748 | 14/20 | 0.53 |
| ▸ | CA9 | Q16790 | 13/20 | 0.53 |
| ▸ | CA12 | O43570 | 12/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 12/20 | 0.53 |
| ▸ | CA5A | P35218 | 11/20 | 0.53 |
| ▸ | CA7 | P43166 | 11/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 11/20 | 0.53 |
| ▸ | CA3 | P07451 | 10/20 | 0.53 |
| ▸ | CA6 | P23280 | 10/20 | 0.53 |
| ▸ | CA13 | Q8N1Q1 | 10/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19382918 | 1.00 | KMT2A (0.58) | KMT2ACA2CA1CA4CA9 | |
| SCHEMBL19382591 | 0.98 | KMT2A (0.56) | KMT2ACA2CA1CA4CA9 | |
| SCHEMBL14315055 | 0.81 | CA2 (0.53) | KMT2ACA2CA1CA4CA9 | |
| SCHEMBL5550978 | 0.78 | KMT2A (0.76) | KMT2A | |
| SCHEMBL14639568 | 0.77 | KMT2A (0.81) | KMT2ACA2CA1 | |
| SCHEMBL14086099 | 0.77 | KMT2A (0.81) | KMT2ACA2CA1 | |
| SCHEMBL793384 | 0.77 | KMT2A (0.85) | KMT2A | |
| SCHEMBL14073776 | 0.76 | KMT2A (0.76) | KMT2A | |
| SCHEMBL19359120 | 0.76 | CA2 (0.77) | CA2CA1CA4CA9CA12 | |
| SCHEMBL8046428 | 0.75 | KMT2A (0.91) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676538-A2 | BI-SPECIFIC ADAPTERS AND THEIR USE WITH UNIVERSAL CAR-T CELLS IN THE TREATMENT OF CAIX-EXPRESSING TUMORS | Purdue Research Foundation (US) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024191887-A2 | BI-SPECIFIC ADAPTERS AND THEIR USE WITH UNIVERSAL CAR-T CELLS IN THE TREATMENT OF CAIX-EXPRESSING TUMORS | PURDUE RESEARCH FOUNDATION (US) | 2024-09-19 | — | — | WO | disclosed |